Cancer News and Research

Latest Cancer News and Research

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

Seattle Genetics, Inc. today announced that the U.S. Food and Drug Administration has granted accelerated approval of ADCETRISTM for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemotherapy regimen.

20 Aug 2011

Research roundup: Majority of Docs face malpractice claims; colonoscopies in older adults; 'overwhelming' Medicare advantage choices

The authors "analyzed malpractice data from 1991 through 2005 for all physicians who were covered by a large professional liability insurer with a nationwide client base" and found that "by the age of 65 years, 75% of physicians in low-risk specialties had faced a malpractice claim, as compared with 99% of physicians in high-risk specialties." Most of those claims did not result in a pyament.

20 Aug 2011

NIH approves BioTime's four GMP human embryonic stem cell lines

BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that four human embryonic stem (hES) cell lines: ESI-035, ESI-049, ESI-051 and ESI-053, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.

20 Aug 2011

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma.

20 Aug 2011

Medicinal Genomics sequences entire genomes of two therapeutic Cannabis strains

Medicinal Genomics, a private company headquartered in Marblehead, Mass., USA and the Netherlands, announced today that it has sequenced the entire genomes of Cannabis sativa and Cannabis indica, representing two strains of the therapeutic plant.

19 Aug 2011

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen

For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.

19 Aug 2011

Echocardiogram may not improve patients' survival rates after elective surgery

A new study has found no evidence that patients who had a heart ultrasound known as an echocardiogram before major surgery had improved survival rates one month or one year after their operation.

19 Aug 2011

NCD Alliance says U.S., Canada, E.U. stalling efforts to fight NCDs

The NCD Alliance, which represents about 2,000 health organizations from around the world focused on non-communicable diseases (NCDs), "on Thursday accused the United States, Canada and Europe of harming efforts to fight cancer, diabetes, heart and other diseases because they will not agree to set United Nations targets," Reuters reports.

19 Aug 2011

New rules would help consumers comparison shop for health plans

The proposed regulations, issued Wednesday by the Department of Health and Human Services, are designed to make sure insurers and employers provide consumers with "plain English" information about health insurance coverage to empower them to make informed choices.

19 Aug 2011

Seven research teams across the U.S. to develop new drugs for nervous system disorders

The National Institutes of Health has made awards to investigators across the United States for an ambitious set of projects seeking to develop new drugs for disorders of the nervous system.

19 Aug 2011

Powerful X-rays help develop new drug treatment for malignant melanoma

Powerful X-ray technology developed at the U.S. Department of Energy's (DOE's) national laboratories is revealing new insights into diseases ranging from Alzheimer's to the swine flu, and, most recently, enabled the discovery of a groundbreaking new drug treatment for malignant melanoma, the deadliest form of skin cancer.

19 Aug 2011

Longer looks: Doctors advocating less care; addiction as a 'disease'

These physicians are not anti-medicine. They are not trying to save money on their copayments or deductibles. And they are not trying to rein in the nation's soaring health-care costs, which at $2.7 trillion account for fully one sixth of every dollar spent in the U.S. They are applying to their personal lives a message they have become increasingly vocal about in their roles as biomedical researchers and doctors: more health care often means worse health.

19 Aug 2011

Single-molecule imaging reveals how cells prepare to interact with biochemical signals

Researchers at Harvard Medical School have discovered that structural elements in the cell play a crucial role in organizing the motion of cell-surface receptors, proteins that enable cells to receive signals from other parts of the organism.

19 Aug 2011

Large-scale population imaging reveals robust sparse coding in Drosophila mushroom body

A research team at Cold Spring Harbor Laboratory (CSHL) led by Assistant Professor Glenn Turner has published results of experiments that show large populations of neurons in the brains of living fruit flies responding simultaneously to a variety of odors.

19 Aug 2011

DiaGenic reports operating revenue of NOK 1,151 thousand for second quarter 2011

DiaGenic: Important milestones achieved. DiaGenic's collaboration with Pfizer is the first collaboration between a diagnostics company and the market leader for Alzheimer's therapeutics that aims to identify blood based diagnostic tools that can detect early Alzheimer's disease, before the disease is clinically overt, or accessible to other either more invasive and costly or less precise diagnostic exploration.

19 Aug 2011

The Perry record on reform, Medicaid and HPV vaccinations

Texas Gov. Rick Perry's high-profile launch of his campaign for the GOP nomination for president means fresh scrutiny on his record and platform regarding health issues.

19 Aug 2011

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.

19 Aug 2011

USPTO issues patent for Spire's nanophotovoltaic device

Spire Corporation, a global solar company providing capital equipment and turn-key manufacturing lines to produce photovoltaic (PV) modules, announced today it has been awarded a patent for its invention of a nanophotovoltaic device which, when applied to biological cells such as cancer, can control and/or limit their growth.

19 Aug 2011

Temple University, URMC partner to translate novel medical research into new drugs

The University of Rochester Medical Center (URMC) and Temple University School of Pharmacy have announced a partnership that will help translate novel medical research into new drugs for treating diseases.

19 Aug 2011

Trans-Anal Minimally Invasive Surgery can remove large polyps with less pain, scarring

For the first time in the western United States, a surgical team lead by Elisabeth McLemore, MD, has used a novel operating platform to perform the scarless removal of rectal tumors. Called Trans-Anal Minimally Invasive Surgery (TAMIS), the technique allows surgeons to excise large polyps and masses that cannot be completely removed during a routine colonoscopy.

19 Aug 2011

Cancer News and Research

Latest Cancer News and Research

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

Research roundup: Majority of Docs face malpractice claims; colonoscopies in older adults; 'overwhelming' Medicare advantage choices

NIH approves BioTime's four GMP human embryonic stem cell lines

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

Medicinal Genomics sequences entire genomes of two therapeutic Cannabis strains

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen

Echocardiogram may not improve patients' survival rates after elective surgery

NCD Alliance says U.S., Canada, E.U. stalling efforts to fight NCDs

New rules would help consumers comparison shop for health plans

Seven research teams across the U.S. to develop new drugs for nervous system disorders

Powerful X-rays help develop new drug treatment for malignant melanoma

Longer looks: Doctors advocating less care; addiction as a 'disease'

Single-molecule imaging reveals how cells prepare to interact with biochemical signals

Large-scale population imaging reveals robust sparse coding in Drosophila mushroom body

DiaGenic reports operating revenue of NOK 1,151 thousand for second quarter 2011

The Perry record on reform, Medicaid and HPV vaccinations

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

USPTO issues patent for Spire's nanophotovoltaic device

Temple University, URMC partner to translate novel medical research into new drugs

Trans-Anal Minimally Invasive Surgery can remove large polyps with less pain, scarring

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in